WO2018232171A1 - Dispositif de transfert de fluide portatif et système - Google Patents

Dispositif de transfert de fluide portatif et système Download PDF

Info

Publication number
WO2018232171A1
WO2018232171A1 PCT/US2018/037624 US2018037624W WO2018232171A1 WO 2018232171 A1 WO2018232171 A1 WO 2018232171A1 US 2018037624 W US2018037624 W US 2018037624W WO 2018232171 A1 WO2018232171 A1 WO 2018232171A1
Authority
WO
WIPO (PCT)
Prior art keywords
injection device
transfer device
vial
support surface
syringe
Prior art date
Application number
PCT/US2018/037624
Other languages
English (en)
Inventor
Dylan L. BOURELLE
Matthew J. Huddleston
Joetta Renee Palmer
David Stefanchik
Original Assignee
Enable Injections, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enable Injections, Inc. filed Critical Enable Injections, Inc.
Priority to JP2019568677A priority Critical patent/JP7128216B2/ja
Priority to CA3066471A priority patent/CA3066471A1/fr
Priority to CN201880051112.6A priority patent/CN110996876B/zh
Priority to US16/621,909 priority patent/US11571360B2/en
Priority to EP18818127.5A priority patent/EP3638186A4/fr
Priority to AU2018285530A priority patent/AU2018285530B2/en
Priority to CN202310819337.4A priority patent/CN117562807A/zh
Publication of WO2018232171A1 publication Critical patent/WO2018232171A1/fr
Priority to JP2022124137A priority patent/JP7414905B2/ja
Priority to JP2023222904A priority patent/JP2024024026A/ja
Priority to AU2024201451A priority patent/AU2024201451A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M5/2066—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically comprising means for injection of two or more media, e.g. by mixing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1493—Containers with shape retaining means, e.g. to support the structure of the container during emptying or filling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2048—Connecting means
    • A61J1/2055—Connecting means having gripping means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2048—Connecting means
    • A61J1/2058—Connecting means having multiple connecting ports
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2048—Connecting means
    • A61J1/2065—Connecting means having aligning and guiding means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2096—Combination of a vial and a syringe for transferring or mixing their contents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14276—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body specially adapted for implantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006—Piercing means
    • A61J1/201—Piercing means having one piercing end
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2048—Connecting means
    • A61J1/2058—Connecting means having multiple connecting ports
    • A61J1/2062—Connecting means having multiple connecting ports with directional valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2068—Venting means
    • A61J1/2075—Venting means for external venting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2079—Filtering means
    • A61J1/2086—Filtering means for fluid filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
    • A61M2005/14252—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type with needle insertion means
    • A61M2005/14256—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type with needle insertion means with means for preventing access to the needle after use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M2005/3114—Filling or refilling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/18—General characteristics of the apparatus with alarm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
    • A61M2205/584—Means for facilitating use, e.g. by people with impaired vision by visual feedback having a color code
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/75—General characteristics of the apparatus with filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/75—General characteristics of the apparatus with filters
    • A61M2205/7527—General characteristics of the apparatus with filters liquophilic, hydrophilic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/75—General characteristics of the apparatus with filters
    • A61M2205/7536—General characteristics of the apparatus with filters allowing gas passage, but preventing liquid passage, e.g. liquophobic, hydrophobic, water-repellent membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00—Ancillary equipment
    • A61M2209/04—Tools for specific apparatus
    • A61M2209/045—Tools for specific apparatus for filling, e.g. for filling reservoirs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/19—Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3287—Accessories for bringing the needle into the body; Automatic needle insertion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/46—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for controlling depth of insertion

Definitions

  • the present subject matter relates generally to a portable transfer device or module for transferring liquid medication from a source vial to an injection device and/or for mixing, diluting or reconstituting a medication and transferring the resulting liquid medication into an injection device.
  • injection devices that are worn by a patient temporarily or for an extended period are well known in the medical field.
  • the subject matter of this application relates to a transfer device for use particularly but not exclusively with the injection device described in PCT Published Application No. WO 2014/204894, published December 24, 2014, and which is hereby incorporated by reference in its entirety.
  • That injection device includes an internal resilient bladder that may be filled with any suitable injectable medicament, whether drug, antibiotic, biologic or other injectable, for subcutaneous injection, typically a bolus injection, into a patient while the device is being worn by the patient.
  • This injection device must be filled (wholly or partially) with the desired injectable before injection into the patient.
  • the above PCT published application also discloses a variety of transfer devices for transferring an injectable into the injection device from a source such as a vial or vials. In some situations, the injectable must be diluted or reconstituted, and various devices are disclosed in the above application for accomplishing that.
  • the present application discloses additional novel designs and improvements, allowing lower cost of manufacture and less waste to dispose, for such transfer devices for transferring, diluting and/or reconstituting.
  • the transfer devices described herein may be variously referred to as transfer modules, accessories, addons or by other suitable terminology, without intending any limitation on the structure or function of the device not set forth herein.
  • Figure 1 is a perspective view of the injection device.
  • Figure 2 is a top view of a filled injection device showing the delivery indicator in a full state.
  • Figure 3 is top view of a filled injection device showing the delivery indicator in an empty state.
  • Figure 4 is a perspective view showing the underside of the injection device with attached tape and fill port.
  • Figure 5 is a perspective view showing the underside of the injection device with tape detached and the fill and dispense ports exposed.
  • Figure 6 is a cross-section of the injection device on the transfer apparatus.
  • Figure 7 is a perspective view of the injection device attached to the skin with the safety device installed.
  • Figure 8 is a perspective view of the injection device attached to the skin with the safety device removed and the button up in a pre-fire state.
  • Figure 9 is a perspective view of the injection device attached to the skin with the safety device removed and the button down in a fired state.
  • Figure 10 is a cross-section view of the injection device attached to the skin with the button up in a pre-fire state.
  • Figure 1 1 is a cross-section view of the injection device attached to the skin with button down in a first fired state.
  • Figure 12 is a cross-section view of the injection device attached to the skin with button down in a dispense state.
  • Figure 13 is a cross-section view of the injection device attached to the skin showing the end of delivery indicator not triggered.
  • Figure 14 is a cross-section view of the injection device attached to the skin showing the end of delivery indicator triggered.
  • Figure 15 is a cross-section view of the injection device attached to the skin with button locked up in a post-fired state.
  • Figure 16 is a perspective view of the injection device removed from the skin with the bandage remaining on the skin.
  • Figure 17 is a perspective view of the injection device with the top housing removed in a filled state.
  • Figure 18 is a top view of the injection device shown in Figure 17.
  • Figure 19 is a perspective view of the injection device with the top housing removed in an empty state.
  • Figure 20 is a top view of the injection device shown in Figure 19.
  • Figure 21 is a perspective view of a transfer device for temporary coupling to an injection device such as the device shown in the figures above for
  • Figure 22 is a perspective view of the transfer device of Figure 21 , taken from a different angle.
  • Figure 23 is a top view of the transfer device of Figure 21 .
  • Figure 24 is a bottom view of the transfer device of Figure 21 .
  • Figure 25 is an end view of the transfer device of Figure 21 looking directly at a syringe adapter.
  • Figure 26 is a side view of the transfer device of Figure 21 .
  • Figure 27 is an opposite side view of the transfer device of Figure 21 .
  • Figure 28 is a perspective view of an injection system including an injection device generally as shown in the above Figures 1 -20, a transfer device as in Figs 21 -27 temporarily coupled thereto, a standard vial and a standard syringe.
  • Figure 29 is a top view of the system of Figure 28.
  • Figure 30 is a bottom view of the system of Figure 28.
  • Figure 31 is a perspective view of a transfer device for temporary coupling to an injection device such as the device shown in the figures above for
  • Figure 32 is a perspective view of a transfer device of Figure 31 , taken from a different angle.
  • Figure 33 is a top view of the transfer device of Figure 31 .
  • Figure 34 is a bottom view of the transfer device of Figure 31 .
  • Figure 35 is an end view of the transfer device of Figure 31 looking directly at a syringe adapter, with portions removed.
  • Figure 36 is a side view of the transfer device of Figure 31 .
  • Figure 37 is an opposite side view of the transfer device of Figure 31 .
  • Figure 38 is an end view of the transfer device of Figure 31 looking directly at a pair of vial adapters.
  • Figure 39 is a perspective view of an injection system including an injection device generally as shown in the above Figures 1 -20, a transfer device as in Figures
  • Figure 40 is a top view of the system of Figure 39.
  • Figure 41 is a bottom view of the system of Figure 39.
  • Figure 42 is a schematic of the flow arrangement of the system of Figure 39 in a first valve position.
  • Figure 43 is a schematic of the flow arrangement of the system of Figure 39 in a second valve position.
  • Figure 44 is a schematic of an alternative flow arrangement of the system of Figure 39.
  • Figure 45 is a bottom view of an alternative one vial transfer device like that shown in Figures 21 -24, but which does not employ a movable valve, and shows an optional hydrophobic filter.
  • Figured 46a and 46b show another embodiment of the transfer device and system that is shown above, the differences being essentially in the transfer device and not in injection device 7.
  • Figure 47 is an exploded perspective view of the transfer device and system shown in Figure 46.
  • Figure 48 is a perspective view of the transfer device base against which the injection device rests when the system is assembled.
  • Figures 49A and 49B are perspective views of a locator ring that attaches to the transfer device base and within which the injection device nests when the system is assembled.
  • Figure 50 is a perspective view of a retainer or harness that holds the injection device against the transfer device base.
  • Figure 51 A is a perspective view of a valve subassembly for controlling the flow of fluid among a syringe, a vial and the injection device.
  • Figure 51 B is a perspective exploded view of the valve subassembly of Figure 51 a.
  • Figure 52 is a perspective view of vial adaptor for receiving a vial of medicament.
  • Figures 53A-53O are pictorial flow charts illustrating selected steps in the use of the transfer device and system.
  • Figure 54 is a perspective view of the injection device as it preferably is located on a patient, illustrating the ergonomic features that encourage user positioning that allows viewing of the injection status indicator.
  • Figure 55 is a perspective view of a hand-held transfer device, injection device mounted thereon and syringe, in which the injection device does not have a manual valve for controlling fluid flow.
  • Figure 56 is bottom view of the hand-held transfer device shown in Figure 55.
  • Figures 57-60 are diagrammatic illustrations of a few examples of potential uses of the hand-held transfer device of Figures 55 and 56.
  • the injection device 7 may be of any suitable configuration, but as illustrated it has a generally low-profile, disc shaped outer housing 74 with an upper surface 75 and a lower surface 76, through which an injection needle or cannula protrudes when actuated by the user.
  • the upper surface 75 has an actuator or button 77 to start the injection and a clear section 80 of the housing 74 that allows the subject or medical professional to view the expandable member 78 to ascertain the amount of injectable fluid 79 in the device 7. For example, the user could determine whether the injection has commenced or concluded. More preferably, the expandable member 78 and/or the clear section 80 of the housing 74 may be
  • the expandable member 78 may itself include or interact with a feature on the outer housing 74 to show the amount of injectable fluid 79 remaining.
  • injectable fluid when the injection device 7 is full of drug 79, the clear section 80 may show one color such as but not limited to green. When the injection device 7 is empty of drug 79, the clear section 80 may show a different color such as but not limited to red. In the middle of dispense, the clear section 80 could show a combination of colors.
  • the undersurface 76 of the injection device 7 includes a filling port 81 and a dispense port 82.
  • the filling port 81 is the interface that allows the transfer apparatus filling tube 83 to transfer liquid 79 to the injection device 7.
  • the dispense port 82 also contains an internal pathway 84 between the expelled injectable 79 from the expandable member 78 and the needle 85.
  • the filling port 81 and dispense port 79 may be in direct fluid communication through internal pathways 86, or they may be combined into a single port.
  • the injection device may preferably include a filling port 81 that includes a check valve 87 to prevent pressurized injectable 79 from leaking out of the injection device 7 when the injection device 7 is removed from the transfer apparatus 6 and the filling port 81 is removed from the filling tube 83.
  • the injection device 7 may also have a filling port 81 that is configured to accept the insertion of a syringe.
  • This syringe may be configured with a luer fitting or a needle.
  • This filling port 81 configuration allows for the manual filling of the injection device by the user.
  • the transfer apparatus 6 may still be used but would not be required in this configuration.
  • the injection device 7 may also have a dispense port 82 that is configured to directly connect to an intravenous cannula via attached tubing or a standard needle port.
  • the undersurface 76 of the injection device 7 carries an adhesive 88 for securing the injection device 7 temporarily to the skin of a subject until the injection is complete.
  • an adhesive tape liner 89 may be removed automatically exposing the adhesive surface 88 on the undersurface 76 of the injection device 7 that may be used to adhere the injection device 7 to the patient's skin.
  • the tape liner 89 may have a tab 90 that the user pulls to manually remove before adhering the injection device 7 to the skin.
  • this tab may be attached to the surface of the transfer device 4 so that the tape liner is automatically removed upon removal of the injection device 7.
  • the injection device 7 may have an adhesive tape flange 91 that extends beyond the undersurface base 76.
  • This flange 91 of adhesive tape 88 can act as a strain relief between the injection device 7 and skin surface, reducing the risk of accidentally dislodging the injection device 7 from the skin.
  • the extended adhesive flange 91 acts to distribute the load on both sides of the connection point between the adhesive tape 88 and the undersurface base 76 of the injection device 7 to reduce any stress risers at the adhesive tape 88 and skin interface.
  • the injection device 7 may be configured with a tapered underside surface 98 that presses on the adhesive flange 91 to securely attach the adhesive tape 88 to the skin as the user is securing the injection device 7 to the skin without additional user intervention.
  • the tapered underside surface 98 of the injection device 7 effectively presses the flange 91 of the adhesive tape 88 against the skin but the upper exposed surface of the flange 91 portion does not have exposed adhesive and therefore is not attached to that portion of the tapered underside surface 98.
  • the user is not required to run their finger around the flange 91 to secure the injection device 7 to the skin making it a much simpler method of adhesive tape 88 attachment.
  • the injection device 7 may have an underside surface 76 that is flexible or compliant in lieu of being rigid to allow for improved attachment by conforming of the injection device 7 to the skin during application.
  • a safety mechanism or lock-out mechanism may be
  • the injection device 7 may use an actuator or button 77 and a visual indicator 101 in combination to define the state of the injection device 7 after it has been removed from the transfer apparatus. For example, when the button 77 is in the up position and the indicator 101 has one color such as but not limited to green, this may indicate that the injection device 7 is ready to start the injection.
  • the button 77 may have a side wall 102 that is a different color from its top 103.
  • the injection device 7 may alert the user when the injection of the drug is completed. This alert could be in the form of visual indicators, audible sounds, mechanical movements or a combination.
  • the button 77 is ideally designed to give the user audible, visual and tactile feedback when the button 77 'pops up' into the locked-out position.
  • the injection device 7 may indicate to the user that it is has completed dispensing and the full dose has been delivered to the patient with the button 77 in the up position and indicator window 101 showing the injection device is empty. For example, when the button 77 is in the up position and indicator 101 shows a different color such as but not limited to red, this may indicate that the injection device 7 has completed the injection.
  • the injection device 7 may have an actuator or button 77 that the user depresses on the injection device 7 to start the injection.
  • the button 77 may be configured to be an on/off switch, i.e., to only have two states, open and closed such as a light switch. This may prevent the user from pushing the button 77 half way and not actuating the injection device 7. Once activated, this 'light switch' type button 77 would insert the needle 85 rapidly into the skin 99, independent of the user manipulation of the button 77. Alternatively, the button 77 could have a continuous motion, allowing the user to slowly insert the needle 85 into skin 99.
  • the button 77 may preferably be directly coupled to the needle 85 by using adhesive 104 creating a button 77 and needle 85.
  • the injection device 7 may have a needle 85 travel into the skin 99, upon actuation of the button 77 that initially goes to a first position or depth as shown in Figure 1 1 and retracts slightly to a second position of depth preferably automatically as shown in Figure 12.
  • the first depth shown in Figure 1 1 is achieved from over travel of the button 77 during actuation.
  • the first depth may be controlled by features 105 in the button 77 in direct contact with the base 106 of the injection device 7.
  • the final depth of the needle 85 is suitable for subcutaneous injections. Alternatively, the final depth of the needle 85 may be reduced for intradermal injections. Alternatively, the final depth of the needle 85 may be increased for intramuscular injections.
  • the needle 85 Upon reaching the first depth, the needle 85 retracts back to a second depth as shown in Figure 12.
  • the retraction distance of the needle to the second depth is in the range of 0.1 -2mm.
  • This retraction feature is preferable to prevent the needle 85 from being blocked by tissue during the initial insertion process. This tissue blockage could require a very high pressure to overcome and prevent the injection device 7 from delivering the drug.
  • the retraction of the needle 85 from the first position to a second position creates an open pocket ahead of the needle tip 107 allowing reduced pressure for initiation of flow of drug from the needle 85. This reduced pressure for initiation of the flow of drug from the needle is preferable for the injection device 7 to maintain a relatively constant pressure during injection.
  • the injection device 7 may include a needle 85 with a side hole 108.
  • the needle 85 will be fully inserted into the skin 99 through the dispense port 82 and the injection device 7 will begin dispensing of the injectable.
  • the side-hole 108 and therefore the internal lumen of the needle 85 is not in communication with the fluid channel 86 of the dispense port 82.
  • Both the side-hole 108 and needle-tip 107 are retained within a septum 109. With the side-hole 108 and needle-tip 107 being retained within the septum 109, the entire drug path is kept sterile until the time of use.
  • a side hole 108 in the needle 85 is in
  • the septum 109 provides the advantage of sealing the needle tip 107 as well as the side hole 108 from the injectable before and after dispense. Sealing the needle tip 107 and the side hole 108 of the needle 85 at the end of the injection has a particular advantage to prevent dripping of injectable from the injection device 7 after end of dispense and/or after it is removed from the skin surface. It also prevents contaminants from entering the hollow needle prior to being actuated into the skin.
  • the septum 109 may be made of any suitable material to allow for sealing once the needle 85 has punctured it.
  • the material composition of septum 109 may preferably be silicone.
  • the material composition of the septum may also be a blend of different materials including but not limited to bromobutyl, chlorobutyl, isoprene, polyisoprene, SBR, polybudtadiene, EPDM, natural rubber and silicone.
  • the fluid pathway 86 including the dispense port 82 could be a rigid plastic with a silicone injected over mold to produce the septum previously described.
  • the septum 109 at the dispense port 82 could protrude slightly from the underneath surface of the injection device 7 into the skin surface 99 to provide for pressure on the skin surface 99 at the injection site. This pressure on the skin surface 99 by the dispense port 82 after the needle is retracted could eliminate injectable from coming out of the injection site, commonly referred to as blowback.
  • the injection device 7 may include a set of spring tabs 1 10 that interface with the button 77 to perform locking functions.
  • a spring tab 1 10 is biased to lock into an undercut 1 1 1 in the button 77 to keep the button 77 in a first up position or pre-fire position as shown in Figure 10.
  • the geometry of the undercut 1 1 1 and spring tab 1 10 help to produce the light switch actuation force described previously. This light switch actuation is accomplished by the translation of the button 77 relative to the spring tab 1 10 and the geometry of the mating undercut 1 1 1 surfaces.
  • the injection device 7 may include a spring tab 1 12 that interacts with the button 77 in the injection device 7 to perform locking functions such that when the button 77 is actuated to the first depth and retracts slightly back to the second depth or dispense position, undercut features 1 13 in the button 77 allow the spring tab 1 12 to hold the button 77 in the dispense position until the injection device 7 has completed dispensing.
  • the injection device 7 may include an end of delivery indication or empty indicator 1 14 to sense when all of the fluid 79 has been expelled from the expandable member 78 and the injection device 7 has completed dispensing.
  • the empty indicator 1 14 may be configured with a slot or other opening 1 15 to slide over the expandable member 78 at the exit port when the expandable member 78 is in a deflated state after all of the fluid has been expelled. There may be two states of the empty indicator. As shown in Figure 13, the empty indicator may be in a first position or deflected-out state when the expandable member 78 is full with fluid 79 at that section and is not contained within the slot or opening 1 15.
  • This first position would translate to a non-empty state of the expandable member 78 when the diameter of the expandable member 78 is larger than its minimum due to residual fluid 79 contained within.
  • the empty indicator 1 14 may be in a second position or deflected-in state when the expandable member 78 is partially or fully contained within the slot or opening 1 15. This second position would translate to an empty state of the expandable member 78 when the diameter is at a minimum.
  • the injection device 7 may include an automatic needle retraction mechanism at the end of dispense.
  • This mechanism includes a direct coupling between a spring tab 1 12, button undercut feature 1 13 and the empty indicator 1 14, all previously mentioned.
  • the expandable member 78 is filled with injectable 79 and the button 77 is depressed from a first pre-fire position to a second dispense position as shown in Figure 14, undercut features 1 13 in the button 77 allow a spring tab 1 12 to hold the button 77 in the dispense position until the injection device 7 has completed dispensing.
  • This spring tab 1 12 may also be directly coupled to the empty indicator 1 14 which is naturally in the first position or deflected-out state.
  • the empty indicator 1 14 (under pretension from the spring tab 1 12) will move to the second position or deflected-in state as shown in Figure 14.
  • the spring tab 1 12 directly coupled to the empty indicator 1 14 also moves with the empty indicator 1 14. This movement releases the spring tab 1 12 from the undercut feature 1 13 in the button 77 to allow the button 77 (and needle) to move up to a final position or post fire position after the dispense is completed as shown in Figure 15.
  • lock out spring tabs 1 17 may also interact with the button 77 in the injection device 7 to perform locking functions such that when the injection is complete the button 77 is released, and the button 77 is urged up by the return spring 1 18 to a final up position or post-fire position.
  • the button height 77 relative to the top of the injection device 7 in the final up position or post-fire position may be higher than the pre-firing position (shown in Figure 10).
  • the end of the lock out spring tabs 1 17 move out to the outer diameter surface 1 19 of the button 77 within the outer housing 74 to lock the button 77 in the up position or post- fire position and prevent the button 77 from being actuated again.
  • the injection device 7 may include a return spring 1 18 that interacts with the button 77 to provide a bias to the button 77 into a first up position or pre-fire position.
  • the return spring 1 18 is compressed causing more of a bias or preload.
  • the button 77 is unlocked from the second depth or dispense position (shown in Figure 12) to move up to a final position or post fire position after the dispense is completed as previously mentioned. It is the bias of the return spring 1 18 that forces the button 77 up to a final position or post-fire position.
  • the injection device 7 upon removal of the injection device 7 from the skin 99, the injection device 7 will preferably be locked out, preventing non-destructive access to the needle or reuse of the injection device 7.
  • the injection device 7 may indicate to the user that the full dose has been delivered. This indication could be in the form of a visual indictor, audible sound, mechanical movement or a combination.
  • a bandage 120 may release from the injection device 7 and remain on the skin surface 35. This can be affected by using an adhesive on the bandage portion that more strongly attaches the bandage to the skin than the adhesive that attaches the bandage to the injection device 7. Thus when the housing is lifted from the skin, the bandage 120 remains in place over the injection site as described in U.S. patent no. 7,637,891 and U.S. patent application no. 12/630996, filed December 4, 2009 incorporated by reference herein.
  • the injection device 7 may preferably include a manifold 121 that assembles to both the expandable member 78 and the filling port 81 and dispensing ports 82, and provides direct fluid communication between the expandable member 78 and the filling 81 and dispensing 82 ports of the injection device 7.
  • the manifold 121 may be configured on the end that assembles to the expandable member 78 to be large in diameter to facilitate filling and expelling all of the fluid 79 out of the expandable member 78 as previously discussed.
  • the manifold 121 may preferably include internal passageways 122 to allow for fluid flow in and out of the expandable member 78.
  • the manifold 121 may be configured with a filter 123 in the injectable fluid pathway 122 for filtering the injectable 79 to remove particulate before and after it is introduced into the expandable member 78.
  • the filter 123 may be a membrane, depth filter or other suitable filtration media that is of sufficiently small pore size or effective pore size to remove objectionable particulate, which may include but not be limited to undissolved injectable 79 in those situations where the injectable 79 is reconstituted by the transfer apparatus.
  • the manifold 121 may also be configured with a filter 123 for the removal of air.
  • a filter 123 for the removal of air.
  • Such an air remover filter 123 may include a bubble trap, air gap or other configuration in the injectable fluid pathway 122 that removes air from the injectable fluid pathway 122 before it is introduced into the expandable member 78.
  • This air remover filter 123 may be configured with a hydrophobic filter or a combination of hydrophobic and hydrophilic filters.
  • a hydrophobic filter would allow for the venting of air from the transfer apparatus but not the passage of liquid.
  • a hydrophilic filter would allow the passage of liquid but not the passage of particulate or air.
  • the air remover filter 123 may also have check valves to allow for venting of trapped air.
  • the air remover and filters 123 may be located at any point in the fluid pathway from the filling port 81 to the needle 85.
  • the most downstream point in the fluid pathway is the distal end 128 of the expandable member 78.
  • An internal mandrel 124 may be connected to distal end 128 of the expandable member 78.
  • An air remover or filter 123 may be integrated into this downstream point to allow for venting of trapped air during filling of the injection device 7.
  • the mandrel 124 could include a slot along its length that is in communication with the downstream filter 123 to aid in the venting of air during the filling process.
  • the injection device 7 may include a resilient expandable member 78 such as an elastomeric balloon or bladder.
  • the material composition of expandable member 78 may preferably be silicone.
  • the material composition of the expandable member 78 may also be a blend of different materials including but not limited to bromobutyl, chlorobutyl, isoprene, polyisoprene, SBR, polybudtadiene, EPDM, natural rubber and silicone.
  • the expandable member 78 may be coated to improve the surface properties. Coatings may include parylene, silicone, Teflon and fluorine gas treatments.
  • the expandable member 78 may be made from a thermoplastic elastomer.
  • the injection device 7 may include a resilient expandable member 78 to which the injectable 79 is transferred under pressure. This causes the expandable member 78 to enlarge and the resilience of the expandable member 78 creates a pressure which tends to expel the injectable 79.
  • the pressure chamber of the transfer apparatus described previously (or such other pump or pressurizing means as may be employed in the transfer apparatus) transfers the injectable 79 to the injection device 7 under pressure. Introducing the injectable 79 into the expandable member 78 under pressure causes it to stretch and expand both in diameter and length. An example of this would be blowing up a long, skinny balloon.
  • the volume range of the injection device 7 may be 0.5 to 30 milliliter.
  • the resilient expandable member 78 When expanded, the resilient expandable member 78 exerts an expulsion pressure in the range of 1 to 200 psi on the injectable 79 contained in the expandable member 78 so that the injection device 7 is ready to administer the injectable 79 automatically when triggered by the user by depression of the button as previously described.
  • the illustrated version of the transfer device 200 may include, among other features, a base 202 that includes an injection device mating or support surface 204, a vial adapter 206, a syringe adapter 208, a flow control valve 210 (see bottom view in Figure 24), and fluid flow path segments 212, 214 and 216 (see bottom view in Figure 24).
  • the transfer device 200 may also include a retaining strap or harness 218 for temporarily securing the transfer device 200 to the injection device 7.
  • the transfer device may be made of one-piece molded plastic construction for low-volume, low cost disposability. Alternatively, one or more features of the transfer device may be separately formed and assembled together to provide the complete transfer device.
  • the support surface 204 may take any of a variety of configurations.
  • the illustrated support surface is generally a circular flat surface that includes an upstanding fluid transfer port 220 positioned off-center to extend into the filling port 81 of injection device 7 when the injection device 7 is placed onto the support surface.
  • the fluid transfer port 220 is generally in the form of a relatively small diameter hollow needle or cannula (which may have a blunt end to avoid accidental needle stick), the lower end of which is in flow communication with flow path segment 214 connected to a lower surface that is opposed to the support surface.
  • the base 202 may include opposed preferential gripping areas 205 (which may also be referred to as finger gaps or gripping or holding zones, regions or locations) that allow the user to grip the injection device 7 in a particular location that encourages, among other benefits, attachment of the injection device 7 to the patient in a preferred orientation.
  • the gripping areas 205 are spaced apart around the peripheral edge of the base and may be, for example, substantially 180 degrees apart.
  • the base may include interfering areas 207 (zones, regions or locations) located between the gripping areas 205 that are configured to interfere with or potentially prevent user gripping of the injection device 7 in those areas - thus encouraging the user to grasp or grip the injection device 7 in the intended preferential gripping areas 205.
  • the base 202 includes preferred gripping areas 205 adjacent the support surface 204.
  • Gripping areas 205 are defined by flat segments along the otherwise generally circular support surface 204 of the base 202.
  • generally circular segments 207 extend between the flat segments of the gripping areas 205 and present interfering areas.
  • the syringe adaptor 208 is illustrated as a standard hollow female luer lock adapter with standard dimensions designed to interfit with the usual standard male syringe luer port located at the discharge end of standard syringes.
  • the radial projections or ears 222 of the luer adapter cooperate with a threaded collar that is located around the male luer port of the standard syringe so that relative rotation secures the male and female luer portions together and avoids accidental or premature disconnection.
  • the syringe adaptor 208 is fluidly connected to one end of fluid flow path segment 212.
  • the vial adaptor 206 includes an external collar 224 that is flared outwardly at the open end for guided reception of the end of a standard vial of injectable.
  • the vial adaptor may include one or more elongated hollow piercing spikes, pins or cannulas 226 for piercing the rubber septum that covers the end of standard medicament vials when a vial is inserted. If one cannula is used, it may include at least a fluid flow lumen for allowing liquid to enter or exit the vial and a venting lumen for allowing displacement air to enter or exit the vial.
  • piercing pins or cannulas may be used, e.g., one cannula for liquid flow and a separate cannula for displacement air.
  • a microporous filter such as a hydrophobic membrane, may be provided to filter displacement air entering the vial while preventing liquid from leaking through the vent air passageway.
  • the fluid flow lumen of the piercing pin or cannula of the vial adaptor 206 is connected to one end of fluid flow path segment 216 on the underside of the base, as will be described below.
  • the harness 218 is pivotally attached at one side of the base 202 and can be pivoted over an associated injection device 7 to straddle the base 202 and injection device 7 and hold the injection device 7 in place.
  • the free end 228 of the harness 218 includes a manually connectable and releasable clip or connector 230 for securing the harness over an injection device 7 and holding it against the base 202 of the transfer device 200 and for releasing the harness 218 and the injection device 7 when fluid transfer into the injection device is completed.
  • the harness 218 has an intermediate ring 232 that extends around or circumscribes the actuator button 77 of the injection device 7.
  • the fluid flow arrangement of the illustrated transfer device 200 is better seen in Figure 24.
  • the fluid flow path segments 212, 214 and 216 may be molded as part of a one-piece transfer device 200 or may be separately formed, such as plastic tubing segments, and secured to the underside of the base 202.
  • the actual flow path configuration can also be varied.
  • the fluid flow path segments 212, 214 and 216 communicate through a centrally located flow control valve 210 shown in the form of a 3-port valve or stopcock.
  • flow path segment 212 extends between the hollow female luer of syringe adapter 208 and the valve 210
  • the flow path segment 214 extends between the hollow cannula of the fluid transfer port 220 and the valve 210
  • the flow path segment 216 extends between the hollow fluid flow piercing spike, pin or cannula 226 of the vial adapter 206 and the valve 210.
  • the three-port valve 210 allows the user to direct/control flow between the syringe adapter 208 and the vial adapter 206 and between the syringe adapter 208 and fluid transfer port 210.
  • valve handle 236 may include visible and/or tactile indicators, such as the triangular indicators 238, seen in Figure 24.
  • Filters may also be positioned in the desired fluid flow segments 212, 214 and 216 to filter the liquid injectable as it passes along the flow path, to remove air bubbles that may be entrained in the liquid and/or to allow displacement air to vent into and from a vial.
  • These filters may be of any suitable type, although microporous membranes of average pore size such as .22 microns may be used for advantageous filtration.
  • Such a filter membrane may be hydrophilic, allowing liquid to pass through, or hydrophobic, allowing gas to pass through and blocking liquid flow, or combination filters in which a portion is hydrophilic and a portion hydrophobic.
  • the position and type of filter will depend on the objective, although one option is to employ a hydrophobic microporous filter membrane in the displacement air flow path to remove pathogens from displacement air passing therethrough while preventing liquid from passing through, and to provide a microporous hydrophilic membrane in the liquid flow path to filter any particulate or pathogens from the liquid while also removing any air bubbles entrained in the liquid. Hydrophilic microporous filters may be provided in each fluid flow path segment if desired.
  • the assembled system 244, including the injection device 7 and transfer device 200, is shown in Figures 28-40 connected to a standard injectable-containing vial 240 and a standard syringe 242.
  • the vial and/or syringe may be attached to the transfer device 200 before or after the transfer device 200 is secured to injection device 7. This arrangement allows for user ease of withdrawal of a liquid injectable from the vial 240 into the syringe 242 and delivery from the syringe into the injection device.
  • injectable can be drawn from the vial 240 into the syringe 242 by simply pulling back on the syringe plunger.
  • the valve handle 236 can then be rotated so that flow path segments 212 and 214 are exclusively in communication and segment 216 is blocked.
  • depression of the syringe plunger forces the liquid injectable from the syringe 242 into the injection device 7, causing the resilient bladder (expandable member 78) to expand as it receives the injectable, and preparing the injection device for subsequent injection into a living subject.
  • Additional vials 240 may be attached and the contents transferred, as needed for the proper dosage. Also, if the injectable requires dilution or reconstitution, the syringe 242 may be provided prefilled with the desired amount of sterile liquid for diluting or reconstituting the injectable. Mixing or reconstitution can be enhanced, if desired, by leaving the valve 210 in the position where the vial 240 and syringe 242are in communication, and repeatedly cycling the syringe plunger to force liquid back and forth between the vial 240 and syringe 242.
  • a hand-held syringe transfer system is provided to allow for a compact and efficient way to remove drug from a vial and move it into a syringe and then into an injection device.
  • the user attaches the vial of drug to the system assembly 244 with the vial adapter 206 of the transfer device 200.
  • the drug vial 240 can have a capacity of 1 -50ml_ with neck finishes of 13-20mm.
  • the syringe 242 capacity can be 1 -50ml_.
  • the injection device 7 capacity can be 1 -50ml_.
  • the user can attach the drug vial to the vial adapter and then attach it to the system.
  • the vial adapter would be part of the system and the user inserts the vial 240 into the system.
  • the vial adapter 240 may contain a spike 226 to access the drug vial 240 through the rubber stopper and has two fluid paths.
  • the syringe 242 is connected to the other side for withdraw of the fluid from the vial 240 and transfer of the fluid into the injection device 7.
  • the valve is positioned to withdraw state creating a fluid path between the syringe 242 and the vial 240.
  • fluid is withdrawn from the vial 240 into the syringe 240.
  • the entire contents of the vial 240 can be removed or partial contents based on the patient's dose.
  • the user can attach multiple vials 240 to fill one syringe 242 to get a necessary dose into the syringe 242. If the fluid is hard to push out of the syringe 242, the user can use multiple syringes 242 to go into the injection device 7 from one or more vials 240. Prior to determining the final dose, there may be some air in the syringe 242. The user can prime the syringe 242 by expelling the excess air in the syringe 242 back into the vial 240.
  • the valve 210 is switched to fill. This creates a fluid path between the filled syringe 242 and the injection device 7.
  • the user pushes on the plunger of the syringe 242 to expel the contents of the syringe 242 into the injection device 7.
  • the system 244 can filter air to prevent air from being transferred into the injection device 7.
  • a filter in the fluid path between the syringe 242 and the injection device 7 can filter the air. This can be accomplished with a hydrophobic filter or combination of hydrophilic/hydrophobic filter, as above discussed.
  • the retaining strap or harness 218 can be unlocked and the filled syringe 242 can be removed from the system 244.
  • the drug may come in a prefilled syringe 242.
  • the valve handle 236 would be moved to the transfer position and the drug pushed into the injection device 7.
  • Multiple prefilled syringes 242 could be used to fill the injection device 7.
  • the transfer device 200 may be readily removed and discarded with little waste, and the injection device 7 applied to the patient.
  • FIGs 31 -44 relate to another embodiment of a transfer device 250 particularly suited for injectables that require reconstitution or dilution.
  • This transfer device 250 includes some characteristics similar to those of the transfer device 200 shown in Figures 21 -30, but includes two vial adapters 262 and a necessarily different flow path arrangement.
  • this transfer device 250 includes a base 252 upon which the injection device 7 rests when coupled thereto.
  • the base 252 forms a support surface 254 from which a fluid transfer port 256 projects for insertion into the filling port 81 of the injection device 7.
  • Raised peripheral walls 258 extend upwardly from the support surface 254, and together they define a nesting or docking site for receiving the injection device 7.
  • the injection device 7 may be temporarily held in the coupled position on the transfer device 250 by opposed flexible hooks 260 that flex outwardly to receive the injection device 7 and hook over the peripheral edge of the disc-shaped injection device 7 to removably retain it on the transfer device 250.
  • a harness arrangement as described earlier may be used for temporarily coupling the transfer device 250 to the injection device 7.
  • the retaining hooks 260 of this embodiment may also be used in the prior single-vial embodiment.
  • the base 252 of this example may include opposed preferential gripping areas 255, which may be referred to as finger gaps or gripping or holding zones, regions or locations and that similarly allow the user to grip the injection device 7 in a particular location that encourages, among other benefits, attachment of the injection device 7 to the patient in a preferred orientation.
  • the gripping areas 255 are spaced apart around the peripheral edge of the base 252 and may be, for example, substantially 180 degrees apart.
  • the base may include interfering areas (zones, regions or locations) located between the gripping areas 255.
  • the gripping areas 255 are defined by flat segments along the otherwise generally circular support surface 254 of the base 252, and the interfering areas are adjacent the support surface 254 and defined by the upward extending raised peripheral walls 258.
  • the peripheral walls 258 extending between the flat segments 255 provide interfering areas that are configured to interfere with or potentially prevent user gripping of the injection device 7 in those areas, so as to encourage the user to grasp or grip the injection device 7 in the intended preferential gripping areas 255.
  • the transfer device 250 includes a pair of vial adapters 262 (262A, 262B), a syringe adapter 264, a fluid flow control valve 266 having a valve handle 266A and associated flow path segments, better seen in other figures.
  • each vial adapter 262 is similar to that described above in the single-vial embodiment, with an external collar 268 and a hollow piercing pin or cannula 270 for piercing the septum that seals the open end of a standard medicine vial.
  • each vial adapter 262 may include a venting feature that allows displacement air to enter or leave the vials and such a venting feature may, for example, be provided as an additional lumen in the piercing pin 270 or as an additional hollow piercing pin or cannula that is devoted to movement of venting air to and from the vial and vented to the atmosphere.
  • Figure 38 which is a view into the vial adapters 262 shows piercing spikes, each with two lumen 270A, 270B - one for liquid introduction and withdrawal and one for venting.
  • FIG. 34 is a view of the underside of the transfer device 250.
  • a fluid flow path segment 274 such as a length of plastic tubing, extends between flow control valve 266 and syringe adapter 264.
  • Fluid flow path segment 276 extends between the flow control valve 266 and the fluid transfer port 256.
  • Fluid flow path segment 278 extends between the flow control valve 266 and the diluent vial adapter 262A
  • fluid flow path segment 280 extends between the flow control valve 266 and the injectable vial adapter 262B.
  • the fluid flow arrangement here allows the ready use of the transfer device 250 when the injectable requires reconstitution or dilution.
  • the injectable vial may be attached to one of the vial adapters 262B and the diluent used to reconstitute or dilute attached to the other vial adapter 262A.
  • the valve handle 266A of the flow control valve 266 is positioned to allow flow between the diluent vial adapter 262A and the syringe 242.
  • reconstitute the injectable may be promoted by manually shaking the entire assembly and/or by cycling the syringe plunger back and forth to repeatedly withdraw fluid from and inject fluid into the injectable vial 240B, causing agitation and mixing of the diluent and injectable.
  • the reconstituted injectable is then collected into the syringe 242. These steps may be carried out before or after coupling of transfer device 250 to the injection device 7, and may be repeated with additional diluent and injectable vials 240A, 240B, if necessary for increased dosage.
  • the injection device 7 will then be coupled to the transfer device 250 and the valve 266 repositioned again to place the syringe 242 (which contains the reconstituted injectable) and fluid transfer port 256 into fluid communication, and depression of the syringe plunger forces the reconstituted injectable through the fluid transfer port 256 and the filling port 81 into the injection device 7, expanding the resilient expandable member or bladder 78 and preparing the injection device for use.
  • the assembled two-vial system 272, including the injection device 7 and transfer device 250, is shown in Figures 39-41 connected to a standard injectable- containing vial 240B, standard diluent containing vial 240A and a standard syringe 242.
  • the vials 240A, 240B and/or syringe 242 may be attached to the transfer device 250 before or after the transfer device 250 is secured to the injection device 7. This arrangement allows for user ease of reconstitution or dilution of the injectable and delivery into the injection device 7.
  • a hand-held reconstitution syringe transfer system is provided to allow for a compact and efficient way reconstitute lyophilized drug, remove drug from a vial and move it into a syringe and then into an injection device.
  • the user attaches the lyophilized drug and diluent vials to the system assembly 272 with the vial adapter(s).
  • Each drug and diluent vial can have a capacity of 1 -50ml_ with neck finishes of 13- 20mm.
  • the syringe 242 capacity can be 1 -50ml_.
  • the injection device 7 capacity can be 1 -50ml_.
  • the user can attach the lyophilized drug and diluent vial(s) to the vial adapter 262, then attach it to the system 272.
  • the vial adapter would be part of the system 272 and the user inserts the vial(s) into the system 272.
  • the vial adapter(s) 262 contain a spike 279 to access the vial through the rubber stopper and has two fluid paths.
  • a first vial adapter with one vented to atmosphere and the other connected to the fluid path. This allows for easy withdraw of the fluid from the vial without creating a vacuum.
  • the other vial spike would allow for connection of two independent sources.
  • the syringe 242 is connected to the other side for withdraw of the fluid from each of the diluent vial 240A and/or reconstituted vial 240B and transfer of the fluid into the injection device 7.
  • the valve 266 is positioned to State 1 creating a fluid path between the diluent vial 240A and syringe 242 and allowing withdraw of the diluent into the syringe 242.
  • fluid is withdrawn from the diluent vial 240A into the syringe 242.
  • the entire contents of the diluent vial 240A can be removed or partial contents based on the patient's dose.
  • the user can attach multiple diluent vials to fill one syringe 242 to get a necessary dose into the syringe 242.
  • the user then can switch the valve to State 2. This creates a fluid path from the filled syringe 242 (with diluent) to the lyophilized vial 240B.
  • the diluent comes in a prefilled syringe.
  • the diluent can be directly transferred to the lyophilized vial. (This can also be accomplished in the single vial system). The user can push on the plunger of the syringe to transfer the contents of the syringe to the lyophilized vial.
  • the lyophilized vial may be under vacuum.
  • the vacuum in the lyophilized vial automatically pulls the diluent into the lyophilized vial.
  • the reconstitution process can begin. The user can manually agitate the diluent/powder mixture until the powder is completely dissolved in solution. The user can then pull back on the syringe plunger to pull the entire contents of the mixed solution or a partial dose, depending on what was prescribed. Prior to determining the final dose, there may be some air in the syringe 242.
  • the user can prime the syringe by expelling the excess air in the syringe back into the vial.
  • the valve is switched to State 3. This creates a fluid path between the filled syringe 242 and the injection device 7.
  • the user pushes on the plunger of the syringe 242 to expel the contents of the syringe into the injection device 7.
  • the system can filter air to prevent air from being transferred into the injection device 7.
  • a filter in the fluid path between the syringe 242 and the injection device can filter the air. This can be accomplished with a hydrophobic filter or combination of hydrophilic/hydrophobic filter.
  • the retaining strap if used, can be unlocked and the filled syringe can be removed from the system.
  • Figures 42 and 43 are schematic flow diagrams that show a dual vial system 272 including an injection device 7 (OBDD) and three way valve 266 or stopcock, connected to a syringe 242, diluent vial (D) 240A and injectable vial (P) 240B, which system also employs check valves 282 that limit flow to one direction only and an air vent 284.
  • Figure 42 shows the valve position for drawing diluent from the diluent vial 240A into the syringe 242
  • Figure 43 shows the valve position after diluent has been drawn into the syringe 242 for injecting the diluent from the syringe 242 into the injectable vial 240B.
  • Figure 44 also a flow schematic, shows a dual vial system 286 but without a central valve or stopcock and instead relying on one-way valves 282 only to control flow.
  • this system 286 vacuum created by pulling back on the syringe plunger draws diluent from the diluent vial 240A through the injectable vial 240B and into the syringe 242.
  • This system 286 may find particular application for injectables that require dilution only or for injectables that readily reconstitute in the presence of diluent.
  • the one-way valves 282 only allow fluid flow in one direction through the system - from the diluent vial 240A to the injectable vial 240B, from the injectable vial 240B to the syringe 242, and from the syringe 242 into the injection device 7 (OBDD).
  • OBDD injection device 7
  • Figure 45 is a bottom view of a transfer device 290 configured to receive one-vial, like the device 200 shown in Figures 21 -24, but which does not use a movable valve.
  • Figure 45 shows a base 291 having lower surface that is opposed to a support surface (not shown in this figure) that is configured to receive an injection device 7.
  • the transfer device 290 includes preferential gripping areas 293 and interfering areas 295, which are located and defined in a similar manner to the gripping areas 205 and interfering areas 207 of the first example transfer device 200.
  • This transfer device 290 also has a vial adapter 292 and a syringe adapter 294 and a fluid flow path with three branches 296, 298 and 300 that are connected to the lower surface of the base 291 and communicate respectively with the vial adapter 292, the syringe adapter 294 and the fluid transfer port (not shown in this figure).
  • Branch 296 includes a one-way or check valve 302 that only allows flow through the branch in a direction from the vial adapter 292. This permits a syringe connected to the syringe adapter 294 to withdraw injectable from a vial attached to the vial adapter 292 and to inject it through the fluid transfer port into an associated injection device without a user having to move any valve.
  • This device 290 may also include an optional hydrophobic filter 304 in communication with branch 300 and the ambient environment. This filter 304 allows any air preceding the injectable ("front end air") to exit or vent to the ambient atmosphere so that such air will not be forced into the injection device. The hydrophobic filter membrane prevents injectable from passing through the vent passageway so that all of the injectable is flowed into the injection device. Such a filter 304 may also be used in flow path segment 276 in the dual vial transfer device.
  • Figures 46-52 illustrate another embodiment of a hand-held transfer device 400 and system 401 .
  • the original element numbers for the injection device 7, vial 240 and syringe 242 will be retained, and new element numbers will be used for the other features of this embodiment.
  • Figures 46a, 46b and 47 depict an assembled transfer system 401 comprising the injection device 7 mounted on a modified transfer device 400, with a vial 240 and syringe 242 attached to the transfer device 400.
  • Figures 46a and 46b are taken from different viewing angles, allowing the assembly to be viewed from opposite sides of transfer device 400.
  • the illustrated transfer device 400 includes base 402 one side of which forms a support surface 404 shown in Figure 47, against which the injection device 7 rests, as seen in Figure 46a.
  • a harness or retainer 406 holds the injection device 7 on the transfer device base 402 within a peripheral locator ring or ring structure 408 that is attached to the base 402.
  • a valve 410 such as a three-way stopcock valve assembly, is mounted on the underside of the base 402 and provides selective fluid communication among the injection vial 240, syringe 242 and injection device 7 when they are, respectively, secured to the valve subassembly 410, vial port 412, syringe port 414 and upstanding injection device fluid transfer port 416 (see Figures 47, 51 a and 51 b) associated with the valve subassembly 410.
  • the basic operating principles for fluid transfer in this embodiment are essentially the same as previously described, and the following description will focus on certain structural differences as compare to the prior
  • the transfer device 400 in this embodiment has particularly helpful ergonomic features that provide a user physical interface which encourages proper user handling and placement of the injection device 7 during the various steps associated with an injection of medicament into a patient/user.
  • the transfer device 400 may include opposed preferential gripping areas (which may also be referred to as finger gaps or gripping or holding zones, regions or locations) that allow the user to grip the injection device in a particular location that encourages, among other benefits, attachment of the injection device 7 to the patient in a preferred orientation.
  • the gripping areas are spaced apart around the peripheral edge of the base and may be, for example, substantially 180 degrees apart.
  • the base may include interfering areas (zones, regions or locations) located between the gripping areas that are configured to interfere with or potentially prevent user gripping of the injection device in those areas - thus
  • one side of the base 402 in this embodiment (which may be referred to as the top side or upper side for convenience only) provides the planar support surface 404 upon which the injection device 7 rests when secured to the base 402.
  • the base 402 of this example may include opposed preferential gripping areas 403, which similarly may be referred to as finger gaps or gripping or holding zones, regions or locations, and that allow the user to grip the injection device 7 in a particular location that may encourage, among other benefits, attachment of the injection device 7 to the patient in a preferred orientation.
  • the gripping areas 403 are spaced apart around the peripheral edge of the base 402 and may be, for example, substantially 180 degrees apart.
  • the gripping areas 403 are defined by flat segments along the otherwise generally circular support surface 404 of the base 402.
  • generally circular segments 405 extend between the flat segments of the gripping areas 403 and present interfering areas that are configured to interfere with or potentially prevent user gripping of the injection device 7 in those areas, so as to encourage the user to grasp or grip the injection device 7 in the intended preferential gripping areas 403.
  • the preferential gripping areas are further defined in part by the locator ring or ring structure 408 that is attached to the base 402.
  • the locator ring 408 is shown as a separate piece (but may be optionally molded as a single piece with the base), and is located on the upper surface of the base, at least partially surrounding the support surface 404.
  • the ergonomic configuration that encourages proper user grasping and placement of the injection device 7 is shown, for example, in Figures 47 and 49a and 49b.
  • the illustrated locator ring 408 defines preferred gripping or holding areas, regions or locations 418 and 420 that force or at least encourage a user to grasp the injection device 7 at those locations and that, in turn, leads to the preferred proper placement of the injection device 7 on the patient when the injection device 7 is removed from the base 402.
  • preferred gripping or holding areas, regions or locations 418 and 420 that force or at least encourage a user to grasp the injection device 7 at those locations and that, in turn, leads to the preferred proper placement of the injection device 7 on the patient when the injection device 7 is removed from the base 402.
  • the gripping areas or regions 418 and 420 are spaced apart, and preferably opposed, to encourage user holding of the injection device 7 between the thumb and one or more of the fingers of the user's hand (better seen in Figures 53B and 53C).
  • the periphery of the injection device 7 may also have opposed flattened portions or flats 500 that are located in registration with the preferred gripping areas 418 and 420 of the ring 408 and the preferred gripping areas 403 of the base 402, when the injection device 7 is mounted on the base 402 to further encourage the desired user gripping.
  • the locator ring 408 defines the preferred holding or gripping areas or regions by the use of opposed portions 418 and 420 of the locator ring 408 that are substantially flush with the support surface 404 when the locator ring or ring structure 408 is mounted thereon.
  • the portions of the locator ring 408 between the holding regions 418 and 420 are configured to form interfering regions (zones or areas) 422 and 424 that tend to block or impede gripping of the transfer device 400 in those regions.
  • the interfering regions 422 and 424 of the locator ring 408 are relatively raised, or elevated from the support surface 404 so as to be located at or above the height of the peripheral edge of the injection device 7 to prevent or as least impede access to the peripheral edge of the injection device 7 in those regions and encourage the patient/user to grip the injection device, instead, in the preferential holding regions or gripping areas 418 and 420.
  • FIG. 49a and 49b where the locator ring 408 may be better viewed, the illustrated (non-limiting) example of a suitable locator ring 408 extends fully 360 degrees and is comprised of opposed gripping areas or holding regions 418 and 420 and opposed interfering regions 422 and 424.
  • raised locator ring segments e.g., segments that only extend for a limited arc
  • Other structures could also be provided that help define preferred gripping areas and interfering areas. Of course, these other structures may not have all the benefits of a locator ring 408 that extends a full 360 degrees to fully encircle the injection device 7.
  • the illustrated locator ring or ring structure 408 is molded of suitable plastic material that may be bonded or otherwise attached to the base 402, and is of a size or diameter slightly larger than the injection device 7 to allow an injection device 7 to be positioned in a nesting type relationship within the locator ring 408 and resting on the generally flat support surface 404 of base 402.
  • the locator ring 408 includes connection pins 426 that extend downwardly at predetermined, non-symmetrical locations that coincide with receiving holes or openings 428 (see Figure 48) located around the periphery of the base 402.
  • connection pins 426 may extend through the receiving holes 428, with the ends flattened or heat swaged to hold the locator ring 408 on the base 402.
  • Other bonding or attachment configurations may also be used.
  • the illustrated ring embodiment also helps protect the injection device 7 during shipping and handling as may be reflected, for example, in drop testing.
  • the locator ring 408 helps protect against impact and also helps prevent undue lateral forces from being applied (upon impact) by the injection device 7 to the upstanding fluid transfer port 416 that extends from the valve 410 through the base 402 and into the injection device 7.
  • the preferential gripping area or holding region 418 of the locator ring 408 has a generally flattened configuration. As more fully explained below, this region cooperates with a particular feature on the base 402 to form an area that is conducive to placement of the user's thumb when gripping the injection device 7. By providing a predictable gripping position for the user's thumb, proper user placement of the injection device 7 on their abdomen of the user can be more predictably assured. This will be more fully explained with reference to Figures 53A-53O.
  • the injection device 7 is secured on the base 402 by retainer or harness 406, seen in Figure 50.
  • the harness 406 holds the injection device on the base 402 during shipping, storage and during many of the preparation steps before an injection.
  • the harness may have other benefits.
  • the harness 406 serves to prevent inadvertent removal of the injection device 7 from the base 402.
  • the harness 406 is located so as to extend over and protect the injection device safety tab 504 (which prevents the actuator button 77 of the injection device from being depressed). In this way, the harness 406 helps prevent mistaken or inadvertent premature removal of the safety tab 504 by the user.
  • the locator ring 408 has harness mounts 430 and 432 located on opposite sides of the locator ring 408 within the interfering regions 422 and 424.
  • Each harness mount includes a pair of spaced harness pin receivers 434 and 436 and an inclined harness ramp latch 438 therebetween.
  • the illustrated harness 406 is a single elongated molded plastic member that extends from one side of the locator ring 408 to the other side, across the top of the injection device 7 to hold the injection device 7 against the support surface 404.
  • a harness connector 440 is located at each end of the harness 406 for securing the harness 406 to the harness mounts 430 and 432 on the ring 408.
  • Each harness connector 440 has a pair of harness mounting pins 442 for receipt in the harness pin receivers 434 and 436 located on the locator ring 408.
  • the harness 406 may also include an injection device interface structure 446 between the ends of the harness 406. As illustrated, the interface structure 446 is configured as a loop (shown as being hexagonal, but any suitable surrounding configuration is also suitable) that extends around the actuator button 77 of the injection device 7.
  • the base 402 may be seen in perspective view in Figure 48.
  • the base generally has a peripheral edge surface or flange 448 that extends around the raised planar support surface 404.
  • the receiving openings 428 for the ring connection pins 426 are located, in this embodiment, in the peripheral flange 448.
  • one or both of the preferential gripping or holding regions 418 and 420 of the locator ring 408 may be of a thickness, such as flattened, so that when resting on the edge flange 448 they are generally flush with the raised support surface 404 upon which the injection device 7 rests. This permits ease of gripping by the user in those areas.
  • the interfering areas or regions 422 and 424 of the locator ring 408 extend around the support surface 404 at a height elevated from the support surface 404. In the interfering areas, the locator ring 408 extends generally along the peripheral edge of the injection device 7 as it rests on the support surface 404. This position of the locator ring 408 in the interfering areas 422 and 424 interferes with user gripping of the peripheral edges of the injection device 7 in those interfering areas.
  • the support surface 404 upon which the injection device 7 rests, has a fluid transfer port 450, through which fluid/drug is introduced into the injection device 7, and a larger central aperture 452 for
  • FIGS 51 a and 51 b illustrate one embodiment of valve 410 may be secured in any suitable manner to the underside of the base 402.
  • the illustrated valve 410 is a 3-way stopcock assembly that controls flow, as explained earlier, among the vial 240, syringe 242 and injection device 7.
  • the valve or stopcock assembly 410 includes the fluid transfer port 416 including an upstanding fluid transfer port tube 454 that extends through fluid transfer port 450 in the support surface 404 of the base 402 for injecting fluid/drug into the injection device 7, the standard syringe female luer lock connection port 414 for connecting to a syringe, such as syringe 242, the male luer lock vial adapter connection port 412 for attaching a vial spike adapter 456 (see Figure 52) and a valve handle 458 for rotating a valve stem 460 to selectively place the syringe port 414 into communication with the vial adapter connection port 412 or the fluid transfer port 416.
  • the fluid transfer port 416 including an upstanding fluid transfer port tube 454 that extends through fluid transfer port 450 in the support surface 404 of the base 402 for injecting fluid/drug into the injection device 7, the standard syringe female luer lock connection port 414 for connecting to a syringe, such as sy
  • a particulate filter 462 such as a nylon membrane or mesh filter, may also be provided in the valve 410 for removing any residual particulate from the fluid or drug as it passes into the fluid transfer port 416 and before it is injected into the injection device 7.
  • the relative positioning of the valve handle 458 and ports 412, 414 and 416 of the transfer device 400 is configured to provide ease of user grasping and
  • vial adapter connection port 412 and the syringe port 414 extend in opposite directions, with the valve handle 458 being located between them and extending at a right angle relative to the ports 412 and 414.
  • This arrangement allows for user grasping of the transfer device assembly 400 in a manner that provides for ease of operation and manipulation of the valve 410 in a natural and intuitive manner.
  • Figure 52 shows the standard vial spike adapter 456 configured for mounting on the luer-type vial adapter connector port 412.
  • the vial adapter 456 includes an internal spike 464 for puncturing a vial septum, and an outer shield 466 to protect against inadvertent touching of the spike 464 and to help guide a vial into the vial adapter 456.
  • Figures 53A-53O illustrate preparation and use of the transfer device 400 and an associated injection device 7, consistent with the system 401 shown in Figure 47.
  • Figures 53A-53J show the PREPARATION steps leading to attachment of the injection device 7.
  • the vial spike adapter 456 is provided as a separate part in its own packaging. The user opens the package and inserts the desired vial 240 into the vial adapter 456, using aseptic technique to avoid contamination.
  • the vial adapter 456, with inserted vial 240, is then connected to the vial adapter connection port 412 of the valve 410 (which is mounted to the underside of the base 402.
  • a syringe 242 is then connected to the syringe connection port 414 of the valve 410, also using aseptic technique - which should be understood to be employed throughout the preparation without the need for further mention.
  • the valve handle 458 is set to allow the syringe 242 to withdraw fluid, such as a drug or other medicament, from the vial 240.
  • the valve handle 458 is then rotated to open the flow path between the syringe 242 and the fluid transfer port 416, which includes upstanding tube 454 that extends through the base 402 and into the injection device filling port 81 .
  • the syringe plunger is depressed to force fluid from the syringe 242 into the injection device 7 until the desired dose is introduced, which may require multiple vials 240.
  • the injection device 7 preferably includes a movable internal indicator or gauge 468 and graduated markings 470 on the injector housing, which indicate the fill condition of the injection device 7 and show to the user the status or progress of the fill and/or injection.
  • the preferential gripping areas 418 and 420 discussed at length above are located to encourage the user to naturally or instinctively place the injector device 7 on the skin of the abdomen with the indicator and markings being on the upper side of the injection device 7 and easily visible to the user when the user looks downwardly toward his or her abdomen.
  • the preferential holding areas 418 and 420 and resultant natural positioning of the injection device 7 on the abdomen also serve to point the release safety tab 504 in the direction of the user's free hand that is not holding the injection device 7.
  • This ergonomic benefit allows the user to continue to grasp and secure the injection device 7 while pulling and removing the safety tab 504 to prepare the device for injection and after removal of the safety tab 504, as shown, to press the injection button 77 with the free hand - at which point the injection needle is advanced into the patient's skin and flow of medicament is started.
  • the preferential placement of the injection device 7 on the abdomen allows the movable indicator and graduated markings to be readily visible to the patient for monitoring injection progress.
  • the injection device 7 is gripped, including a tab 506 that is associated with the adhesive attachment member and extends radially outwardly for ease of gripping with the injection device 7. Removal of the injection device 7 from the skin simultaneously lifts the tab 506 and pulls the adhesive member from the skin.
  • FIG. 55 and 56 show a hand-held transfer device without a manual fluid flow control valve.
  • Figure 55 is a perspective view of an assembled system including a handheld transfer device 600 (without a manual flow control valve), with an injection device or injector 7 mounted thereon and a standard syringe 242 secured to the transfer device 600.
  • the transfer device 600 is essentially the same as that described earlier, except that it does not have a manual flow control valve.
  • the handheld transfer device includes a syringe port 602 that is directly connected by flow tubing 604 to a fluid transfer port assembly 606 that extends from the support surface (not shown) of the transfer device as previously described for introduction of medical fluid into the injection device 7. No flow control valve or vial port of vial adapter is needed.
  • Figures 57-60 show diagrammatic examples of how the hand-held transfer device 600 may be used.
  • the medical fluid could be provided in a pre-filled syringe 242, and injected directly into transfer device 600 for introduction the injection device 7.
  • no vial port, vial adapter or manual flow control valve of any type would be required.
  • the illustrated injection device 7 has a built-in one-way valve that prevents backflow of medical fluid from the reservoir located in the injection device 7, so in this configuration, no fluid flow control valve is needed.
  • the syringe 242 may not be pre-filled by the drug manufacturer, but medical fluid may be withdrawn from a vial 240 directly into a syringe 242 via a standard vial adapter, and then the filled syringe 242 could be detached from the vial adapter and attached to the transfer device 600 to inject the medical fluid directly through the transfer device 600 into the injection device 7 mounted thereon - and no manual valve, vial port or adapter would be needed on the transfer device 600.
  • the syringe 242 would be attached to the vial 240 using a standard vial adapter and the drug reconstituted or diluted with diluent from the vial 240, and then drawn into the syringe 242.
  • the syringe 242 would be detached from the vial adapter, attached to the transfer device 600 and the reconstituted medical fluid injected directly into the injection device 7.
  • no valve, vial port or adapter would be needed on the transfer device 600 for this application.
  • a further variation of the preceding example would use two vials - a vial 240A with diluent fluid, a vial 240B with powdered or concentrated liquid drug, an empty syringe 242 and a vial adapter for each vial.
  • the syringe 242 could be used to draw diluent from the diluent vial 240A, via a diluent vial adapter, and then, after disconnection from the diluent vial adapter, be attached to the drug vial 240B, via the drug vial adapter and thereby reconstitute the powdered drug or dilute the concentrated drug.
  • a hand-held transfer device could include an attached vial adapter and have no valve.

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Fluid Mechanics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Un dispositif de transfert jetable a une surface de support de dispositif d'injection pour recevoir un dispositif d'injection sur le corps sur celui-ci et un agencement de trajet d'écoulement pour le transfert de fluide dans le dispositif d'injection, le dispositif de transfert étant configuré pour définir des zones de préhension préférentielles pour la préhension par l'utilisateur d'un dispositif d'injection lorsqu'un tel dispositif est situé sur la surface de support et des zones d'interférence pour interférer avec la préhension par l'utilisateur du dispositif d'injection dans les zones d'interférence.
PCT/US2018/037624 2017-06-15 2018-06-14 Dispositif de transfert de fluide portatif et système WO2018232171A1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP2019568677A JP7128216B2 (ja) 2017-06-15 2018-06-14 携帯用流体移送装置およびシステム
CA3066471A CA3066471A1 (fr) 2017-06-15 2018-06-14 Dispositif de transfert de fluide portatif et systeme
CN201880051112.6A CN110996876B (zh) 2017-06-15 2018-06-14 手持式流体转移装置和系统
US16/621,909 US11571360B2 (en) 2017-06-15 2018-06-14 Hand-held fluid transfer device and system
EP18818127.5A EP3638186A4 (fr) 2017-06-15 2018-06-14 Dispositif de transfert de fluide portatif et système
AU2018285530A AU2018285530B2 (en) 2017-06-15 2018-06-14 Hand-held fluid transfer device and system
CN202310819337.4A CN117562807A (zh) 2017-06-15 2018-06-14 手持式流体转移装置和系统
JP2022124137A JP7414905B2 (ja) 2017-06-15 2022-08-03 携帯用流体移送装置およびシステム
JP2023222904A JP2024024026A (ja) 2017-06-15 2023-12-28 液体薬剤の移送方法
AU2024201451A AU2024201451A1 (en) 2017-06-15 2024-03-05 Hand-held fluid transfer device and system

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762520335P 2017-06-15 2017-06-15
US62/520,335 2017-06-15
US201762571419P 2017-10-12 2017-10-12
US62/571,419 2017-10-12

Publications (1)

Publication Number Publication Date
WO2018232171A1 true WO2018232171A1 (fr) 2018-12-20

Family

ID=64660689

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2018/037624 WO2018232171A1 (fr) 2017-06-15 2018-06-14 Dispositif de transfert de fluide portatif et système

Country Status (7)

Country Link
US (1) US11571360B2 (fr)
EP (1) EP3638186A4 (fr)
JP (3) JP7128216B2 (fr)
CN (2) CN117562807A (fr)
AU (2) AU2018285530B2 (fr)
CA (1) CA3066471A1 (fr)
WO (1) WO2018232171A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021094548A1 (fr) * 2019-11-13 2021-05-20 Activoris Medizintechnik Gmbh Adaptateur pour système de mélange et d'injection de médicament
US11317944B2 (en) 2011-03-14 2022-05-03 Unomedical A/S Inserter system with transport protection
US11458292B2 (en) 2019-05-20 2022-10-04 Unomedical A/S Rotatable infusion device and methods thereof
US11617827B2 (en) 2005-09-12 2023-04-04 Unomedical A/S Invisible needle
US11771841B2 (en) 2020-12-23 2023-10-03 Tolmar International Limited Systems and methods for mixing syringe valve assemblies
USD1029245S1 (en) 2022-06-22 2024-05-28 Tolmar International Limited Syringe connector

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018165588A1 (fr) * 2017-03-10 2018-09-13 Enable Injections, Inc. Dispositif, système et procédé de reconstitution
US20210299336A1 (en) * 2020-03-25 2021-09-30 Covidien Lp Outflow collection systems for hysteroscopic surgical procedures
US20230364336A1 (en) * 2022-05-16 2023-11-16 Medtronic Minimed, Inc. Device for transferring and conditioning infusion liquid and related technology

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100305507A1 (en) * 2009-05-27 2010-12-02 Duncan David R Compact non-electric medicament infuser
WO2014204894A2 (fr) * 2013-06-18 2014-12-24 Enable Injections, Llc Procédé et appareil de transfert de flacon et d'injection
WO2015003145A1 (fr) * 2013-07-03 2015-01-08 Deka Products Limited Partnership Appareil, système et procédé pour administrer un fluide
US20150151041A1 (en) * 2012-08-22 2015-06-04 Roche Diagnostics Operations, Inc. Automatic Device for Transferring Fluid
US20160271382A1 (en) * 2013-10-14 2016-09-22 Medtronic Minimed, Inc. Therapeutic Agent Injection Device

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7128105B2 (en) * 2004-04-07 2006-10-31 Forhealth Technologies, Inc. Device for reconstituting a drug vial and transferring the contents to a syringe in an automated matter
US7731678B2 (en) * 2004-10-13 2010-06-08 Hyprotek, Inc. Syringe devices and methods for mixing and administering medication
WO2007053799A2 (fr) * 2005-10-19 2007-05-10 Cd Solutions, Llc Appareil et procede de melange et de transfert de medicaments
US7815609B2 (en) * 2007-12-19 2010-10-19 Calibra Medical, Inc. Disposable infusion device positive pressure filling apparatus and method
CA2951841C (fr) 2008-07-18 2018-07-10 Becton, Dickinson And Company Ensemble pompe a engrenages et double compartiment pour systeme d'administration sous haute pression
US9662621B2 (en) 2012-03-09 2017-05-30 Sensile Pat Ag Drug reconstitution system
US9789027B2 (en) * 2012-07-12 2017-10-17 Antares Pharma, Inc. Liquid-transfer adapter beveled spike
CN203970912U (zh) * 2014-07-28 2014-12-03 冯邦玺 一次性全封闭吸、配药注射连接器
US11478583B2 (en) * 2014-10-03 2022-10-25 Enable Injections, Inc. Medical fluid transfer and injection apparatus and method
US11033680B2 (en) * 2015-07-17 2021-06-15 Enable Injections, Inc. Fluid flow control valve and flow control devices and methods employing same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100305507A1 (en) * 2009-05-27 2010-12-02 Duncan David R Compact non-electric medicament infuser
US20150151041A1 (en) * 2012-08-22 2015-06-04 Roche Diagnostics Operations, Inc. Automatic Device for Transferring Fluid
WO2014204894A2 (fr) * 2013-06-18 2014-12-24 Enable Injections, Llc Procédé et appareil de transfert de flacon et d'injection
WO2015003145A1 (fr) * 2013-07-03 2015-01-08 Deka Products Limited Partnership Appareil, système et procédé pour administrer un fluide
US20160271382A1 (en) * 2013-10-14 2016-09-22 Medtronic Minimed, Inc. Therapeutic Agent Injection Device

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11617827B2 (en) 2005-09-12 2023-04-04 Unomedical A/S Invisible needle
US11317944B2 (en) 2011-03-14 2022-05-03 Unomedical A/S Inserter system with transport protection
US11458292B2 (en) 2019-05-20 2022-10-04 Unomedical A/S Rotatable infusion device and methods thereof
US11944775B2 (en) 2019-05-20 2024-04-02 Unomedical A/S Rotatable infusion device and methods thereof
WO2021094548A1 (fr) * 2019-11-13 2021-05-20 Activoris Medizintechnik Gmbh Adaptateur pour système de mélange et d'injection de médicament
US11771841B2 (en) 2020-12-23 2023-10-03 Tolmar International Limited Systems and methods for mixing syringe valve assemblies
US11931559B2 (en) 2020-12-23 2024-03-19 Tolmar International Limited Systems and methods for mixing syringe valve assemblies
USD1029245S1 (en) 2022-06-22 2024-05-28 Tolmar International Limited Syringe connector

Also Published As

Publication number Publication date
JP2020523131A (ja) 2020-08-06
JP2024024026A (ja) 2024-02-21
CA3066471A1 (fr) 2018-12-20
US20210145697A1 (en) 2021-05-20
AU2024201451A1 (en) 2024-04-04
EP3638186A4 (fr) 2021-03-31
CN110996876A (zh) 2020-04-10
JP7128216B2 (ja) 2022-08-30
CN110996876B (zh) 2023-07-25
JP2022153629A (ja) 2022-10-12
AU2018285530A1 (en) 2020-01-02
US11571360B2 (en) 2023-02-07
CN117562807A (zh) 2024-02-20
EP3638186A1 (fr) 2020-04-22
JP7414905B2 (ja) 2024-01-16
AU2018285530B2 (en) 2024-03-28

Similar Documents

Publication Publication Date Title
AU2018285530B2 (en) Hand-held fluid transfer device and system
US20210268178A1 (en) Vial Transfer and Injection Apparatus and Method
JP7269294B2 (ja) 再構成装置、システムおよび方法
US20080114295A1 (en) Drug delivery device with sliding valve and methodology
CN111629703A (zh) 加压气体动力液体转移装置和系统

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18818127

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 3066471

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2019568677

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2018285530

Country of ref document: AU

Date of ref document: 20180614

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2018818127

Country of ref document: EP

Effective date: 20200115